External use Chinese herba preparation for treatment of herpes zoster syndrome and preparation method thereof

Abstract

The invention discloses an external use Chinese herba preparation for treatment of a herpes zoster syndrome and a preparation method thereof. The external use Chinese herba preparation is prepared from, by weight, 20-70 g of gamboge, 10-50 g of realgar, 5-25 g of dried alum, 10-50 g of coptis chinensis, 0.5-1.5 g of musk and 1900-2100 ml of 75%-95% ethyl alcohol. The effective medicinal compositions are prepared into solvent to be applied to wounded parts. The external use Chinese herba preparation has a special effect on treatment of viral diseases such as herpes zoster, ulcer carbuncle and mosquito injuries, medicine can go deep into subcutaneous tissue to kill viruses, the medicine can take effect quickly, the course of treatment is short, the treatment rate is high, and the effective rate reaches 100%.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation for external use for treating herpes zoster and a preparation method thereof. technical background [0002] Herpes zoster is an acute skin and mucous membrane infection caused by the herpes zoster virus. After the virus is infected, it exists in the ganglion cells of the spinal or cranial nerves in a latent form for a long time. After being activated by certain factors, the virus reaches the skin from one or several ganglia along the corresponding peripheral nerves, causing recurrent infection, that is, herpes zoster . Clinically, it is characterized by sudden onset, along the nerve band, unilateral distribution, and dense clusters of herpes, with obvious pain. The clinical treatment of herpes zoster is mainly based on intravenous infusion of acyclovir, adenosine arabinoside and cytarabine antiviral therapy, supplemented by intramuscular injection of interferon, which has slow effica...

AI Technical Summary

Problems solved by technology

The clinical treatment of herpes zoster is mainly based on intravenous infusion of acyclovir, adenosine vidarabine, and cytarabin